discovermagazine - Learn how personalized genetic therapy helped researchers treat two children with a rare form of epilepsy, enabling one to walk independently for the first time.
AI Summary: Two children with a rare, treatment‑resistant epilepsy mutation showed marked clinical improvement after receiving individualized genetic therapies—one via an antisense oligonucleotide tailored to the mutation. The cases underscore the promise of bespoke molecular medicines for devastating pediatric neurological disorders and hint that precision medicine can be both life‑changing and, yes, kind of miraculous.
Single‑infusion gene editing dramatically lowers LDL cholesterol in early trial / 7 wks
Drug-induced hibernation shows promise to limit stroke brain injury / 4 wks
Stem cells show potent promise as a diabetes treatment / 2 months
Mid‑stage Parkinson trial failure halts drug development plans / 2 months
Gene therapy restores hearing in about 90% of trial participants / 3 months
First-in-human trial primes immune system to accept donor livers / 3 months
Experimental therapy significantly reduces Parkinson’s toxic protein in early trial / 3 months
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.